<DOC>
	<DOCNO>NCT01445067</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetics ( PK ) BMS-927711 migraine non-migraine condition .</brief_summary>
	<brief_title>Study Evaluate PK BMS-927711 Patient With Migraine During Acute Migraine Non-migraine Condition</brief_title>
	<detailed_description>Study Classification : Safety CGRP = Calcitonin gene relate peptide</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Patients migraine without aura otherwise healthy determine medical history , physical examination , clinical laboratory evaluation 12lead electrocardiogram ( ECG ) , eligible Men woman [ woman childbearing potential ( WOCBP ) Women non childbearing potential ( WONCBP ) ] age 1855 year inclusive , body mass index ( BMI ) 18.0 32.0 kg/m2 8 migraine month Patient least 1 year history migraine ( without aura ) include follow : 1 . Meet diagnostic criterion migraine history least 1 year ( without aura ) screen visit 2 . Migraine attack age onset prior 55 year old 3 . Migraine attack , average , last 472 hour untreated 3 month prior screen visit 28 moderate severe migraine attack per month 3 month prior screen visit . The migraine , patient receives treatment study , must least one associate symptom : nausea , photophobia , phonophobia , migraine aura Female patient pregnant/breastfeeding ( female expect conceive study period ) Patient history evidence stroke/transient ischemic attack , heart disease , coronary artery vasospasm , significant underlie cardiovascular disease , uncontrolled hypertension ( high blood pressure ) , uncontrolled diabetes , Human Immunodeficiency Virus ( HIV ) Patient exclude take medication acute migraine 10 day per month , frequent chronic tension type headaches 15 day per month ( unable distinguish tensiontype headache migraine ) Patient major depression , pain syndrome might interfere study assessment , psychiatric condition , dementia , significant neurological disorder ( migraine ) Patient history gastric , small intestinal surgery , disease cause mal absorption Patient history current evidence unstable medical condition ( eg , history congenital heart disease arrhythmia , know suspected infection , hepatitis B C , cancer ) , investigator 's opinion , would expose undue risk significant adverse event ( AE ) interfere assessment safety efficacy course trial Patient basilar migraine hemiplegic migraine Patient take narcotic medication History alcohol , substance drug abuse within last year Uses opiate first line acute treatment migraine attack History ergotamine , acute therapy triptan intake great than/equal 10 day per month regular basis great than/equal 3 month History simple analgesic intake great than/equal 10 day per month great than/equal 3 month History use opioid combination medication intake butalbital containing analgesic great 5 day per month great than/equal 3 month Do receive migraine relief triptan migraine treatment Evidence renal impairment calculate creatinine clearance &lt; 60ml/min clinically relevant find urinalysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
</DOC>